aluates Reports

$ 0.0

Automative

Global Messenger RNA Vaccines and Therapeutics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-25B14524

Global Messenger RNA Vaccines and Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Messenger RNA Vaccines and Therapeutics Market Research Report 2025

Code: QYRE-Auto-25B14524

Report

May 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

BioNTech

Moderna, Inc

CureVac

Pfizer Inc

Daiichi Sankyo Company

Intellia Therapeutics

Arcturus Therapeutics

CSPC

Fosun Pharma

Glaxo Smith Kline's

Emmy Vaccine

CanSino

Messenger RNA Vaccines and Therapeutics Market Size

The global market for Messenger RNA Vaccines and Therapeutics was valued at US$ 13420 million in the year 2024 and is projected to reach a revised size of US$ 30450 million by 2031, growing at a CAGR of 12.6% during the forecast period.

Messenger RNA Vaccines and Therapeutics Market

An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.

North American market for Messenger RNA Vaccines and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Messenger RNA Vaccines and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Messenger RNA Vaccines and Therapeutics in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Messenger RNA Vaccines and Therapeutics include BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics, Emmy Vaccine, CSPC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Messenger RNA Vaccines and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Messenger RNA Vaccines and Therapeutics.

The Messenger RNA Vaccines and Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Messenger RNA Vaccines and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Messenger RNA Vaccines and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Messenger RNA Vaccines and Therapeutics Market Report

Report Metric	Details
Report Name	Messenger RNA Vaccines and Therapeutics Market
Accounted market size in year	US$ 13420 million
Forecasted market size in 2031	US$ 30450 million
CAGR	12.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Self-amplifying Conventional Non-amplifying
Segment by Application	Cancer Infectious Diseases Autoimmune Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics, Emmy Vaccine, CSPC, CanSino, Fosun Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Messenger RNA Vaccines and Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Messenger RNA Vaccines and Therapeutics Market growing?

Ans: The Messenger RNA Vaccines and Therapeutics Market witnessing a CAGR of 12.6% during the forecast period 2025-2031.

What is the Messenger RNA Vaccines and Therapeutics Market size in 2031?

Ans: The Messenger RNA Vaccines and Therapeutics Market size in 2031 will be US$ 30450 million.

Who are the main players in the Messenger RNA Vaccines and Therapeutics Market report?

Ans: The main players in the Messenger RNA Vaccines and Therapeutics Market are BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, Daiichi Sankyo Company, Intellia Therapeutics, Arcturus Therapeutics, Emmy Vaccine, CSPC, CanSino, Fosun Pharma

What are the Application segmentation covered in the Messenger RNA Vaccines and Therapeutics Market report?

Ans: The Applications covered in the Messenger RNA Vaccines and Therapeutics Market report are Cancer, Infectious Diseases, Autoimmune Diseases, Others

What are the Type segmentation covered in the Messenger RNA Vaccines and Therapeutics Market report?

Ans: The Types covered in the Messenger RNA Vaccines and Therapeutics Market report are Self-amplifying, Conventional Non-amplifying

Recommended Reports

mRNA Vaccine Markets

Traditional & Viral Vaccines

Gene and RNA Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Self-amplifying

1.2.3 Conventional Non-amplifying

1.3 Market by Application

1.3.1 Global Messenger RNA Vaccines and Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Infectious Diseases

1.3.4 Autoimmune Diseases

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Messenger RNA Vaccines and Therapeutics Market Perspective (2020-2031)

2.2 Global Messenger RNA Vaccines and Therapeutics Growth Trends by Region

2.2.1 Global Messenger RNA Vaccines and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Messenger RNA Vaccines and Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Messenger RNA Vaccines and Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Messenger RNA Vaccines and Therapeutics Market Dynamics

2.3.1 Messenger RNA Vaccines and Therapeutics Industry Trends

2.3.2 Messenger RNA Vaccines and Therapeutics Market Drivers

2.3.3 Messenger RNA Vaccines and Therapeutics Market Challenges

2.3.4 Messenger RNA Vaccines and Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Messenger RNA Vaccines and Therapeutics Players by Revenue

3.1.1 Global Top Messenger RNA Vaccines and Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Top Messenger RNA Vaccines and Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Messenger RNA Vaccines and Therapeutics Revenue

3.4 Global Messenger RNA Vaccines and Therapeutics Market Concentration Ratio

3.4.1 Global Messenger RNA Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Messenger RNA Vaccines and Therapeutics Revenue in 2024

3.5 Global Key Players of Messenger RNA Vaccines and Therapeutics Head office and Area Served

3.6 Global Key Players of Messenger RNA Vaccines and Therapeutics, Product and Application

3.7 Global Key Players of Messenger RNA Vaccines and Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Messenger RNA Vaccines and Therapeutics Breakdown Data by Type

4.1 Global Messenger RNA Vaccines and Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Messenger RNA Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031)

5 Messenger RNA Vaccines and Therapeutics Breakdown Data by Application

5.1 Global Messenger RNA Vaccines and Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Messenger RNA Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Messenger RNA Vaccines and Therapeutics Market Size (2020-2031)

6.2 North America Messenger RNA Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025)

6.4 North America Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Messenger RNA Vaccines and Therapeutics Market Size (2020-2031)

7.2 Europe Messenger RNA Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025)

7.4 Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Messenger RNA Vaccines and Therapeutics Market Size (2020-2031)

9.2 Latin America Messenger RNA Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioNTech

11.1.1 BioNTech Company Details

11.1.2 BioNTech Business Overview

11.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Introduction

11.1.4 BioNTech Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.1.5 BioNTech Recent Development

11.2 Moderna

11.2.1 Moderna Company Details

11.2.2 Moderna Business Overview

11.2.3 Moderna Messenger RNA Vaccines and Therapeutics Introduction

11.2.4 Moderna Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.2.5 Moderna Recent Development

11.3 CureVac

11.3.1 CureVac Company Details

11.3.2 CureVac Business Overview

11.3.3 CureVac Messenger RNA Vaccines and Therapeutics Introduction

11.3.4 CureVac Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.3.5 CureVac Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Introduction

11.4.4 Pfizer Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Glaxo Smith Kline's

11.5.1 Glaxo Smith Kline's Company Details

11.5.2 Glaxo Smith Kline's Business Overview

11.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Introduction

11.5.4 Glaxo Smith Kline's Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.5.5 Glaxo Smith Kline's Recent Development

11.6 Daiichi Sankyo Company

11.6.1 Daiichi Sankyo Company Company Details

11.6.2 Daiichi Sankyo Company Business Overview

11.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Introduction

11.6.4 Daiichi Sankyo Company Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.6.5 Daiichi Sankyo Company Recent Development

11.7 Intellia Therapeutics

11.7.1 Intellia Therapeutics Company Details

11.7.2 Intellia Therapeutics Business Overview

11.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Introduction

11.7.4 Intellia Therapeutics Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.7.5 Intellia Therapeutics Recent Development

11.8 Arcturus Therapeutics

11.8.1 Arcturus Therapeutics Company Details

11.8.2 Arcturus Therapeutics Business Overview

11.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Introduction

11.8.4 Arcturus Therapeutics Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.8.5 Arcturus Therapeutics Recent Development

11.9 Emmy Vaccine

11.9.1 Emmy Vaccine Company Details

11.9.2 Emmy Vaccine Business Overview

11.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Introduction

11.9.4 Emmy Vaccine Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.9.5 Emmy Vaccine Recent Development

11.10 CSPC

11.10.1 CSPC Company Details

11.10.2 CSPC Business Overview

11.10.3 CSPC Messenger RNA Vaccines and Therapeutics Introduction

11.10.4 CSPC Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.10.5 CSPC Recent Development

11.11 CanSino

11.11.1 CanSino Company Details

11.11.2 CanSino Business Overview

11.11.3 CanSino Messenger RNA Vaccines and Therapeutics Introduction

11.11.4 CanSino Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.11.5 CanSino Recent Development

11.12 Fosun Pharma

11.12.1 Fosun Pharma Company Details

11.12.2 Fosun Pharma Business Overview

11.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Introduction

11.12.4 Fosun Pharma Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

11.12.5 Fosun Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

BioNTech

Moderna, Inc

CureVac

Pfizer Inc

Daiichi Sankyo Company

Intellia Therapeutics

Arcturus Therapeutics

CSPC

Fosun Pharma

Glaxo Smith Kline's

Emmy Vaccine

CanSino

List of Tables

Table 1. Global Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Self-amplifying

Table 3. Key Players of Conventional Non-amplifying

Table 4. Global Messenger RNA Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Messenger RNA Vaccines and Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Messenger RNA Vaccines and Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Messenger RNA Vaccines and Therapeutics Market Share by Region (2020-2025)

Table 8. Global Messenger RNA Vaccines and Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Messenger RNA Vaccines and Therapeutics Market Share by Region (2026-2031)

Table 10. Messenger RNA Vaccines and Therapeutics Market Trends

Table 11. Messenger RNA Vaccines and Therapeutics Market Drivers

Table 12. Messenger RNA Vaccines and Therapeutics Market Challenges

Table 13. Messenger RNA Vaccines and Therapeutics Market Restraints

Table 14. Global Messenger RNA Vaccines and Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Messenger RNA Vaccines and Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Messenger RNA Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Messenger RNA Vaccines and Therapeutics as of 2024)

Table 17. Ranking of Global Top Messenger RNA Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Messenger RNA Vaccines and Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Messenger RNA Vaccines and Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Messenger RNA Vaccines and Therapeutics, Product and Application

Table 21. Global Key Players of Messenger RNA Vaccines and Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Messenger RNA Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Messenger RNA Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Messenger RNA Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Messenger RNA Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. BioNTech Company Details

Table 47. BioNTech Business Overview

Table 48. BioNTech Messenger RNA Vaccines and Therapeutics Product

Table 49. BioNTech Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 50. BioNTech Recent Development

Table 51. Moderna Company Details

Table 52. Moderna Business Overview

Table 53. Moderna Messenger RNA Vaccines and Therapeutics Product

Table 54. Moderna Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Moderna Recent Development

Table 56. CureVac Company Details

Table 57. CureVac Business Overview

Table 58. CureVac Messenger RNA Vaccines and Therapeutics Product

Table 59. CureVac Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 60. CureVac Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Messenger RNA Vaccines and Therapeutics Product

Table 64. Pfizer Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Glaxo Smith Kline's Company Details

Table 67. Glaxo Smith Kline's Business Overview

Table 68. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product

Table 69. Glaxo Smith Kline's Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Glaxo Smith Kline's Recent Development

Table 71. Daiichi Sankyo Company Company Details

Table 72. Daiichi Sankyo Company Business Overview

Table 73. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product

Table 74. Daiichi Sankyo Company Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Daiichi Sankyo Company Recent Development

Table 76. Intellia Therapeutics Company Details

Table 77. Intellia Therapeutics Business Overview

Table 78. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product

Table 79. Intellia Therapeutics Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Intellia Therapeutics Recent Development

Table 81. Arcturus Therapeutics Company Details

Table 82. Arcturus Therapeutics Business Overview

Table 83. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product

Table 84. Arcturus Therapeutics Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Arcturus Therapeutics Recent Development

Table 86. Emmy Vaccine Company Details

Table 87. Emmy Vaccine Business Overview

Table 88. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product

Table 89. Emmy Vaccine Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Emmy Vaccine Recent Development

Table 91. CSPC Company Details

Table 92. CSPC Business Overview

Table 93. CSPC Messenger RNA Vaccines and Therapeutics Product

Table 94. CSPC Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 95. CSPC Recent Development

Table 96. CanSino Company Details

Table 97. CanSino Business Overview

Table 98. CanSino Messenger RNA Vaccines and Therapeutics Product

Table 99. CanSino Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 100. CanSino Recent Development

Table 101. Fosun Pharma Company Details

Table 102. Fosun Pharma Business Overview

Table 103. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product

Table 104. Fosun Pharma Revenue in Messenger RNA Vaccines and Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Fosun Pharma Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Messenger RNA Vaccines and Therapeutics Picture

Figure 2. Global Messenger RNA Vaccines and Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Messenger RNA Vaccines and Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Self-amplifying Features

Figure 5. Conventional Non-amplifying Features

Figure 6. Global Messenger RNA Vaccines and Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Messenger RNA Vaccines and Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Infectious Diseases Case Studies

Figure 10. Autoimmune Diseases Case Studies

Figure 11. Others Case Studies

Figure 12. Messenger RNA Vaccines and Therapeutics Report Years Considered

Figure 13. Global Messenger RNA Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Messenger RNA Vaccines and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Messenger RNA Vaccines and Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Messenger RNA Vaccines and Therapeutics Market Share by Players in 2024

Figure 17. Global Messenger RNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Messenger RNA Vaccines and Therapeutics Revenue in 2024

Figure 19. North America Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Messenger RNA Vaccines and Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Messenger RNA Vaccines and Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Messenger RNA Vaccines and Therapeutics Market Share by Region (2020-2031)

Figure 33. China Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Messenger RNA Vaccines and Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Messenger RNA Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. BioNTech Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 49. Moderna Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 50. CureVac Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 52. Glaxo Smith Kline's Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 53. Daiichi Sankyo Company Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 54. Intellia Therapeutics Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 55. Arcturus Therapeutics Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 56. Emmy Vaccine Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 57. CSPC Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 58. CanSino Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 59. Fosun Pharma Revenue Growth Rate in Messenger RNA Vaccines and Therapeutics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global Veterinary mRNA Vaccines Market Research Report 2025

Global Livestock mRNA Vaccines Market Research Report 2025

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global RNA Vaccines Market Insights Forecast to 2030

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global mRNA Synthesis Manufacturing Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Vaccine Raw Materials Market Research Report 2024

Global mRNA Therapy Market Research Report 2024

Global Nucleic Vaccine Market Insights Forecast to 2030

Global mRNA Vaccine Core Enzyme Market Research Report 2025

Global Travelers Vaccines Market Research Report 2025

Global Travelers Vaccination Market Research Report 2025

mRNA COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Vaccine Market Insights Forecast to 2030

Global Human Vaccination Market Research Report 2025

Global Flu RNA Vaccines Market Research Report 2025

Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions